Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Bone marrow adipose tissue does not express UCP1 during development or adrenergic-induced remodeling

Craft CS., Robles H., Lorenz MR., Hilker ED., Magee KL., Andersen TL.

Animal Study on Type 2 Diabetes, published in Sci Rep (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31758074
PMCID
PMC6874537
DOI
10.1038/s41598-019-54036-x
Citations
28

Abstract (original English)

Adipocytes within the skeleton are collectively termed bone marrow adipose tissue (BMAT). BMAT contributes to peripheral and local metabolism, however, its capacity for cell-autonomous expression of uncoupling protein 1 (UCP1), a biomarker of beige and brown adipogenesis, remains unclear. To overcome this, Ucp1-Cre was used to drive diphtheria toxin expression in cells expressing UCP1 (Ucp1 Cre+/DTA+ ). Despite loss of brown adipose tissue, BMAT volume was not reduced in Ucp1 Cre+/DTA+ mice. Comparably, in mTmG reporter mice (Ucp1 Cre+/mTmG+ ), Ucp1-Cre expression was absent from BMAT in young (3-weeks) and mature (16-weeks) male and female mice. Further, β3-agonist stimulation failed to induce Ucp1-Cre expression in BMAT. This demonstrates that BMAT adipocytes are not UCP1-expressing beige/brown adipocytes. Thus, to identify novel and emerging roles for BMAT adipocytes in skeletal and whole-body homeostasis, we performed gene enrichment analysis of microarray data from adipose tissues of adult rabbits. Pathway analysis revealed genetic evidence for differences in BMAT including insulin resistance, decreased fatty acid metabolism, and enhanced contributions to local processes including bone mineral density through candidate genes such as osteopontin. In sum, this supports a paradigm by which BMAT adipocytes are a unique subpopulation that is specialized to support cells within

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
SkeletonAdipose TissueAdipocytesBone MarrowAnimalsMiceAdrenergic AgentsFluorescent Antibody TechniqueGene ExpressionGene Expression Regulation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research